Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Royal Marsden Hospital · Erasmus MC Cancer Institute · +20 more institutions
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
1,163
total citations
- FWCI
- 59.87
- Percentile
- 100%
- References
- 30
Citations per year
Authors
19Topics & keywords
Topics
Keywords
- Ifosfamide
- Doxorubicin
- Soft tissue sarcoma
- Medicine
- Sarcoma
- Oncology
- Soft tissue
- Chemotherapy
No related works found for this paper.
Funding
- AAmgen
- AUAarhus Universitet
- AUAarhus Universitetshospital
- NBNIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- CRCancer Research UK
- NINational Institute for Health and Care Research
- UCUniversity College London
- ECEORTC Charitable Trust
- UMUniversitair Medisch Centrum Groningen
- UZUniversität zu Köln
- UDUniversität Duisburg-Essen
- CCCanadian Cancer Society Research InstituteAwards: 021039, grant 021039
- UZUniversitaire Ziekenhuizen Leuven, KU Leuven